knowledge -WSS

knowledge

author：focus 2025-09-30 23:45:27 - browse：729

WASHINGTON, DC - NOVEMBER 27: U.S. President Joe Biden speaks about supply chain resilience during an event in the Indian Treaty Room at the Eisenhower Executive Office Building on November 27, 2023 in Washington, DC. — President Biden spoke about supply chain resilience and drug shortages. Alex Wong/Getty Images

WASHINGTON — President Biden’s new plan to curb drug shortages by boosting domestic drug production won’t expand the supply of the chemotherapies that are currently in shortage, an administration official confirmed. The limited scope surprised experts, who told STAT Biden could have included those drugs in the effort.

The 15 cancer drugs in short supply account for only a little more than 10% of the drugs on FDA’s shortage list. But chemotherapies are far more crucial than many other drugs experiencing shortages, which include injections of amino acids and multivitamins, and sterile water. Gut-wrenching stories about cancer patients being switched to less-effective drugs have caused cancer doctors to agitate for government solutions.

Biden announced last week that he plans to use the Defense Production Act to get companies to make essential medicines and their ingredients in the United States. The administration will spend $35 million to boost domestic production of key starting materials for drugs that hospitals commonly use and are prone to shortages.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： Eliminate the waiting period for sterilization covered by Medicaid

hotspot

leisure time

WSS

Eliminate the waiting period for sterilization covered by Medicaid

Patient advocates debate FDA's accelerated approval process

Roche subsidiary Foundation Medicine opens new headquarters

States should stop sabotaging methadone treatment reform

Eliminate the waiting period for sterilization covered by Medicaid

Why the world’s most expensive drug might be worth the price

Wikipedia

knowledge

hotspot

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

The Readout: Lenmeldy, GLP

As demand for Covid shots wanes, Moderna seeks its next success

Abortion pill Supreme Court ruling could impact entire drug industry

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

The Readout: Lenmeldy, GLP

23andMe had bad news about my health. I wish a person had delivered it

Readout Newsletter: Merck, Vertex, and Viking updates

Medicare details structure of new drug price negotiation program

Supreme Court mifepristone arguments center on docs' right to sue

focus

Will generative AI in health care meet the fate of IBM's Dr. Watson?

Readout Newsletter: Cardior, Regeneron, Nuvation, Dyne and more

Patient advocates debate FDA's accelerated approval process

Steward Health Care has deal to sell doctor network to UnitedHealth

Readout Newsletter: Blackstone Life Sciences, Merck, Bluebird Bio

Merck drug for rare lung condition set for approval in U.S.

knowledge

hotspot

leisure time

knowledge